Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers
- PMID: 17537911
- PMCID: PMC1891217
- DOI: 10.1073/pnas.0703900104
Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers
Abstract
The metastatic spread of epithelial cancer cells from the primary tumor to distant organs mimics the cell migrations that occur during embryogenesis. Using gene expression profiling, we have found that the FOXC2 transcription factor, which is involved in specifying mesenchymal cell fate during embryogenesis, is associated with the metastatic capabilities of cancer cells. FOXC2 expression is required for the ability of murine mammary carcinoma cells to metastasize to the lung, and overexpression of FOXC2 enhances the metastatic ability of mouse mammary carcinoma cells. We show that FOXC2 expression is induced in cells undergoing epithelial-mesenchymal transitions (EMTs) triggered by a number of signals, including TGF-beta1 and several EMT-inducing transcription factors, such as Snail, Twist, and Goosecoid. FOXC2 specifically promotes mesenchymal differentiation during an EMT and may serve as a key mediator to orchestrate the mesenchymal component of the EMT program. Expression of FOXC2 is significantly correlated with the highly aggressive basal-like subtype of human breast cancers. These observations indicate that FOXC2 plays a central role in promoting invasion and metastasis and that it may prove to be a highly specific molecular marker for human basal-like breast cancers.
Conflict of interest statement
Conflict of interest statement: S.A.M., J.Y., and R.A.W. are inventors of a patent application in part based on findings described in this manuscript.
Figures
Similar articles
-
Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes.Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15449-54. doi: 10.1073/pnas.1004900107. Epub 2010 Aug 16. Proc Natl Acad Sci U S A. 2010. PMID: 20713713 Free PMC article.
-
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.Cell. 2004 Jun 25;117(7):927-39. doi: 10.1016/j.cell.2004.06.006. Cell. 2004. PMID: 15210113
-
FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer.Breast Cancer Res. 2015 Feb 26;17(1):30. doi: 10.1186/s13058-015-0531-1. Breast Cancer Res. 2015. PMID: 25848863 Free PMC article.
-
AKT-ions with a TWIST between EMT and MET.Oncotarget. 2016 Sep 20;7(38):62767-62777. doi: 10.18632/oncotarget.11232. Oncotarget. 2016. PMID: 27623213 Free PMC article. Review.
-
Protein kinase CK2 in breast cancer: the CK2β regulatory subunit takes center stage in epithelial plasticity.Cell Mol Life Sci. 2015 Sep;72(17):3305-22. doi: 10.1007/s00018-015-1929-8. Epub 2015 May 20. Cell Mol Life Sci. 2015. PMID: 25990538 Free PMC article. Review.
Cited by
-
Copper-Based Nanomedicines for Cuproptosis-Mediated Effective Cancer Treatment.Biomater Res. 2024 Oct 18;28:0094. doi: 10.34133/bmr.0094. eCollection 2024. Biomater Res. 2024. PMID: 39430913 Free PMC article. Review.
-
Lack of basic rationale in epithelial-mesenchymal transition and its related concepts.Cell Biosci. 2024 Aug 20;14(1):104. doi: 10.1186/s13578-024-01282-w. Cell Biosci. 2024. PMID: 39164745 Free PMC article. Review.
-
Molecular expression of Forkhead Box C2 gene (FOXC2) and Prospero homeobox gene (PROX-1) in oral squamous carcinoma and their correlation with clinicopathological parameters: A prospective cohort study.J Oral Maxillofac Pathol. 2024 Apr-Jun;28(2):216-225. doi: 10.4103/jomfp.jomfp_394_23. Epub 2024 Jul 11. J Oral Maxillofac Pathol. 2024. PMID: 39157851 Free PMC article.
-
The role of transcription factor FOXA1/C2/M1/O3/P1/Q1 in breast cancer.Medicine (Baltimore). 2024 Apr 12;103(15):e37709. doi: 10.1097/MD.0000000000037709. Medicine (Baltimore). 2024. PMID: 38608123 Free PMC article.
-
Evaluating differences in optical properties of indolent and aggressive murine breast tumors using quantitative diffuse reflectance spectroscopy.Biomed Opt Express. 2023 Nov 2;14(12):6114-6126. doi: 10.1364/BOE.505153. eCollection 2023 Dec 1. Biomed Opt Express. 2023. PMID: 38420330 Free PMC article.
References
-
- Fidler IJ. Nat Rev Cancer. 2003;3:453–458. - PubMed
-
- Hay ED. Acta Anat (Basel) 1995;154:8–20. - PubMed
-
- Thiery JP. Nat Rev Cancer. 2002;2:442–454. - PubMed
-
- Thiery JP, Chopin D. Cancer Metastasis Rev. 1999;18:31–42. - PubMed
-
- Savagner P, Boyer B, Valles AM, Jouanneau J, Thiery JP. Cancer Treat Res. 1994;71:229–249. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials